360 related articles for article (PubMed ID: 16731579)
1. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha.
Vanden Heuvel JP; Thompson JT; Frame SR; Gillies PJ
Toxicol Sci; 2006 Aug; 92(2):476-89. PubMed ID: 16731579
[TBL] [Abstract][Full Text] [Related]
2. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
Takacs ML; Abbott BD
Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.
Intrasuksri U; Rangwala SM; O'Brien M; Noonan DJ; Feller DR
Gen Pharmacol; 1998 Aug; 31(2):187-97. PubMed ID: 9688458
[TBL] [Abstract][Full Text] [Related]
4. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.
Bjork JA; Butenhoff JL; Wallace KB
Toxicology; 2011 Oct; 288(1-3):8-17. PubMed ID: 21723365
[TBL] [Abstract][Full Text] [Related]
5. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
Rosen MB; Das KP; Rooney J; Abbott B; Lau C; Corton JC
Toxicology; 2017 Jul; 387():95-107. PubMed ID: 28558994
[TBL] [Abstract][Full Text] [Related]
6. Transcription of genes involved in fat metabolism in chicken embryos exposed to the peroxisome proliferator-activated receptor alpha (PPARα) agonist GW7647 or to perfluorooctane sulfonate (PFOS) or perfluorooctanoic acid (PFOA).
Strömqvist M; Olsson JA; Kärrman A; Brunström B
Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jun; 156(1):29-36. PubMed ID: 22465071
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species.
Ren H; Vallanat B; Nelson DM; Yeung LWY; Guruge KS; Lam PKS; Lehman-McKeeman LD; Corton JC
Reprod Toxicol; 2009 Jun; 27(3-4):266-277. PubMed ID: 19162173
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
[TBL] [Abstract][Full Text] [Related]
9. The effects of perfluorinated chemicals on adipocyte differentiation in vitro.
Watkins AM; Wood CR; Lin MT; Abbott BD
Mol Cell Endocrinol; 2015 Jan; 400():90-101. PubMed ID: 25448844
[TBL] [Abstract][Full Text] [Related]
10. Activation of human nuclear receptors by perfluoroalkylated substances (PFAS).
Behr AC; Plinsch C; Braeuning A; Buhrke T
Toxicol In Vitro; 2020 Feb; 62():104700. PubMed ID: 31676336
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays.
Evans N; Conley JM; Cardon M; Hartig P; Medlock-Kakaley E; Gray LE
Toxicol Appl Pharmacol; 2022 Aug; 449():116136. PubMed ID: 35752307
[TBL] [Abstract][Full Text] [Related]
12. Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Zomer AW; van Der Burg B; Jansen GA; Wanders RJ; Poll-The BT; van Der Saag PT
J Lipid Res; 2000 Nov; 41(11):1801-7. PubMed ID: 11060349
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferators and fatty acids negatively regulate liver X receptor-mediated activity and sterol biosynthesis.
Johnson TE; Ledwith BJ
J Steroid Biochem Mol Biol; 2001 Apr; 77(1):59-71. PubMed ID: 11358675
[TBL] [Abstract][Full Text] [Related]
15. Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors.
Johnson TE; Holloway MK; Vogel R; Rutledge SJ; Perkins JJ; Rodan GA; Schmidt A
J Steroid Biochem Mol Biol; 1997; 63(1-3):1-8. PubMed ID: 9449199
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha.
Tobin KA; Steineger HH; Alberti S; Spydevold O; Auwerx J; Gustafsson JA; Nebb HI
Mol Endocrinol; 2000 May; 14(5):741-52. PubMed ID: 10809236
[TBL] [Abstract][Full Text] [Related]
17. Subtype- and response element-dependent differences in transactivation by peroxisome proliferator-activated receptors alpha and gamma.
Kassam A; Hunter J; Rachubinski RA; Capone JP
Mol Cell Endocrinol; 1998 Jun; 141(1-2):153-62. PubMed ID: 9723896
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.
Kim MS; Sweeney TR; Shigenaga JK; Chui LG; Moser A; Grunfeld C; Feingold KR
Metabolism; 2007 Feb; 56(2):267-79. PubMed ID: 17224343
[TBL] [Abstract][Full Text] [Related]
19. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver.
Anderson SP; Dunn C; Laughter A; Yoon L; Swanson C; Stulnig TM; Steffensen KR; Chandraratna RA; Gustafsson JA; Corton JC
Mol Pharmacol; 2004 Dec; 66(6):1440-52. PubMed ID: 15371561
[TBL] [Abstract][Full Text] [Related]
20. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
